PALO ALTO, Calif.--(BUSINESS WIRE)--CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced its participation at the JMP Securities Healthcare Conference to be held July 12-13 in New York. Mark Monane, M.D., the company’s chief medical officer, will provide an overview of CardioDx and of Corus® CAD, the first and only clinically validated gene expression test for obstructive coronary artery disease. The presentation will take place on Thursday, July 12 at 9:30 a.m. ET at the Peninsula Hotel.
